Compare Bekasi Asri Pemula Tbk (BAPA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bekasi Asri Pemula Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bekasi Asri Pemula Tbk trades at Rp240 (market cap 186.62B, 71.44M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Bekasi Asri Pemula Tbk is more actively traded (71.44M versus 159.2K). Which is the better fit depends on your goals.
| BAPA | DGNS | |
|---|---|---|
Market Cap | 186.62B | 310.75B |
Volume | 71.44M | 159.2K |
Lot | 714.38K | 1.59K |
Turnover | 18.3B | 34.72M |
Average Price | 256.12 | 218.06 |
Value | 18.3B | 34.72M |
Indicative Equilibrium Price | 240 | 220 |
Indicative Equilibrium Volume | 16.81K | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bekasi Asri Pemula Tbk
PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.
Read more on BAPA →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
